Physician profile
Marlee S Greschner
NPI 1457890188
$590.21
in general payments reported to CMS, 2019-2025
11 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $211 · 2023: $174 · 2024: $67.87 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $378.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $167.85 | 2023-2024 | Hemoblast Bellows |
| Intuitive Surgical, INC. | $89.11 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.63 | 2023-2025 | |
| Organon LLC | $68.28 | 2022-2023 | Nexplanon, Nuvaring |
| Conmed Corporation | $53.57 | 2022 | |
| Sage Therapeutics, LLC | $38.08 | 2025 | Zurzuvae |
| Zimvie INC. | $29.35 | 2023 | |
| Supernus Pharmaceuticals, INC. | $18.85 | 2025 | Qelbree |
| Pfizer INC. | $17.77 | 2025 | |
| Abbvie INC. | $14.10 | 2022 | |
| Mayne Pharma Commercial LLC | $6.62 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlee Greschner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.